350 Odcinki

  1. Episode 169: Dan Diamond on covering Biden, plus the FDA's future, & the latest Aduhelm twist

    Opublikowany: 15.07.2021
  2. Episode 168: Aduhelm's latest twist, & how Covid variants are shaping the summer

    Opublikowany: 8.07.2021
  3. Episode 167: George Yancopoulos on biotech in 2021, plus a CRISPR milestone, Biogen's FDA saga,

    Opublikowany: 1.07.2021
  4. Episode 166: FDA inner workings, GSK's foggy future, & the alarming rise in colorectal cancer

    Opublikowany: 24.06.2021
  5. Episode 165: Paul Offit on the Covid vaccine booster debate, & Robyn Karnauskas' call of the decade

    Opublikowany: 17.06.2021
  6. Episode 164: Every angle on the FDA's polarizing approval of Biogen's Alzheimer's drug

    Opublikowany: 10.06.2021
  7. Episode 163: Marilynn Marchione on covering the CRISPR babies scandal

    Opublikowany: 3.06.2021
  8. Episode 162: Scott Gottlieb on Covid and grilling, plus how Zolgensma has changed SMA

    Opublikowany: 27.05.2021
  9. Episode 161: Biotech meme stocks, the lessons of Spanish Flu, & becoming a pandemic celebrity

    Opublikowany: 20.05.2021
  10. Episode 160: Global Covid-19 failures, a sluggish CDC, and a boisterous STAT Health Tech Summit

    Opublikowany: 13.05.2021
  11. Episode 159: Thomas Bollyky on patent waivers, plus vaccine riches, & a gene therapy for aging

    Opublikowany: 6.05.2021
  12. Episode 158: Angela Rasmussen on Russia's vaccine controversy, plus Biden's drug pricing punt

    Opublikowany: 29.04.2021
  13. Episode 157: Mercedes Carnethon on outdoor masking, FDA in limbo, & gene therapy's uncertain upside

    Opublikowany: 22.04.2021
  14. Episode 156: J&J's vaccine pause, talking about remote risks, & why no new drugs for Covid-19

    Opublikowany: 15.04.2021
  15. Episode 155: AstraZeneca's vaccine woes, compassionate use, & giving out Covid vaccines

    Opublikowany: 8.04.2021
  16. Episode 154: Eleanor Fox on Illumina’s FTC headache, plus Talkspace’s experiment

    Opublikowany: 1.04.2021
  17. Episode 153: AstraZeneca and the very good, then quite bad, then deeply confusing week

    Opublikowany: 25.03.2021
  18. Episode 152: Alison Buttenheim on Europe's vaccine scare, Lilly's Alzheimer's data, & a PR plea

    Opublikowany: 18.03.2021
  19. Episode 151: Natasha Loder on Covid vaccines, the demise of Watson Health, and a 'synbio' explainer

    Opublikowany: 11.03.2021
  20. Episode 150: Ashish Jha on Covid-19 optimism, plus pharma cooperation, & the next pandemic phase

    Opublikowany: 4.03.2021

10 / 18

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Visit the podcast's native language site